DVAX is a 100 million dollar company, with a chance at billions in revenue. Yeah I know what you’re saying, “Thats what biotech companies are, and they’re a dime a dozen”. Once again somewhat true to the average trader, but if you do your due diligence you’ll find a DVAX is an Option Call.
How many small micro cap biotechs have 20% insider ownership, hardly any short interest, multi hundred million dollar vaccine very close to approval. As well as some promising Flu vaccine data. When I used to trade this company in 2005 it would move from $4 to $6 on the Flu vaccine hopes alone HEPLISAV I hadn’t heard of.
Never invest more than you can afford to lose in a company like this but as an ex. $5,000 has a great chance of turning into $15,000 to $20,000 by the end of the year. I THINK THATS an Option Call!
are you holding peix anymore?
No but I’m gonna go buy some right here @ .86x.88